Clinical Trial Update: Assessment of the Impact of Gadolinium Injection on the Measurement of the QSM Signal

View source ↗

Summary

This completed clinical trial assessed the impact of gadolinium injections on measuring quantitative susceptibility mapping (QSM) signals. The study focused on …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• White Matter Disease

Drugs mentioned

• Gadolinium-based contrast agent (gadolinium-based contrast agent)

Snippet

Sponsor: Fondation Ophtalmologique Adolphe de Rothschild | Conditions: White Matter Disease | Status: COMPLETED